ALK and renal cell carcinoma: There is no standard treatment for patients with ALK-rearranged RCC; however, a recent study found that ALK-rearranged RCC with VCL as a fusion gene did not generally exhibit recurrence or distant metastasis [72], while ALK-rearranged RCC accompanied by other fusion genes showed a more aggressive clinical course [73].